We are live on ! Find out more
DCMM

DG Capital Management (Massachusetts) Portfolio holdings

AUM $102M
1-Year Est. Return 29.14%
This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+29.14%
3 Year Est. Return
+96.74%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$166M
AUM Growth
-$109K
Cap. Flow
-$7.01M
Cap. Flow %
-4.23%
Top 10 Hldgs %
29.78%
Holding
76
New
12
Increased
23
Reduced
29
Closed
11

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.02M
2
CSIQ icon
Canadian Solar
CSIQ
+$2.54M
3
ULTA icon
Ulta Beauty
ULTA
+$2.21M
4
BMY icon
Bristol-Myers Squibb
BMY
+$1.6M
5
ABBV icon
AbbVie
ABBV
+$1.46M

Top Sells

Rank Stock Value
1
CB icon
Chubb
CB
+$2.79M
2
TXN icon
Texas Instruments
TXN
+$2.45M
3
AMGN icon
Amgen
AMGN
+$2.42M
4
HAR
Harman International Industries
HAR
+$2.32M
5
TSN icon
Tyson Foods
TSN
+$1.89M

Sector Composition

Rank Sector Weight
1 Healthcare 39.3%
2 Financials 15.77%
3 Technology 11.18%
4 Communication Services 8.59%
5 Industrials 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMZN icon
26
Amazon
AMZN
$2.94T
$2.8M 1.69%
129,100
-46,800
-27% -$978K
PARA
27
DELISTED
Paramount Global Class B
PARA
$2.8M 1.69%
50,465
+4,705
+10% +$284K
MS icon
28
Morgan Stanley
MS
$336B
$2.74M 1.65%
70,690
+5,830
+9% +$222K
INTU icon
29
Intuit
INTU
$88.1B
$2.71M 1.63%
26,915
+205
+0.8% +$20.9K
JAZZ icon
30
Jazz Pharmaceuticals
JAZZ
$16.7B
$2.66M 1.61%
15,131
+1,635
+12% +$294K
SCHW
31
Charles Schwab
SCHW
$187B
$2.43M 1.47%
74,500
+1,605
+2% +$50.7K
CELG
32
DELISTED
Celgene Corp
CELG
$2.4M 1.45%
20,730
-2,010
-9% -$230K
MON
33
DELISTED
Monsanto Co
MON
$2.39M 1.44%
22,425
+1,025
+5% +$119K
BUD icon
34
AB InBev
BUD
$165B
$2.38M 1.43%
19,715
-3,110
-14% -$382K
REGN icon
35
Regeneron Pharmaceuticals
REGN
$79.5B
$2.38M 1.43%
4,655
-1,025
-18% -$500K
ABT icon
36
Abbott
ABT
$187B
$2.36M 1.42%
48,026
-2,410
-5% -$116K
NXPI icon
37
NXP Semiconductors
NXPI
$58.4B
$2.35M 1.41%
23,893
-8,195
-26% -$840K
ILMN icon
38
Illumina
ILMN
$29.3B
$2.33M 1.4%
10,958
-2,966
-21% -$579K
DAL icon
39
Delta Air Lines
DAL
$60.5B
$2.29M 1.38%
55,810
-26,135
-32% -$1.14M
HON icon
40
Honeywell
HON
$76.3B
$2.29M 1.38%
24,951
+22
+0.1% +$2.05K
HDB icon
41
HDFC Bank
HDB
$122B
$2.23M 1.34%
147,348
-12,440
-8% -$181K
ULTA icon
42
Ulta Beauty
ULTA
$23.2B
$2.22M 1.34%
+14,355
New +$2.21M
CSIQ icon
43
Canadian Solar
CSIQ
$1.05B
$2.12M 1.27%
+73,935
New +$2.54M
MRSH
44
Marsh
MRSH
$92.2B
$2M 1.21%
35,273
-8,810
-20% -$509K
HDS
45
DELISTED
HD Supply Holdings, Inc.
HDS
$1.94M 1.17%
55,020
-5,560
-9% -$185K
GOOG icon
46
Alphabet (Google) Class C
GOOG
$4.36T
$1.83M 1.11%
69,220
-2,196
-3% -$58.8K
BBWI icon
47
Bath & Body Works
BBWI
$4.06B
$1.76M 1.06%
25,365
+9,340
+58% +$670K
APC
48
DELISTED
Anadarko Petroleum
APC
$1.74M 1.05%
22,256
+2,340
+12% +$203K
VRTX icon
49
Vertex Pharmaceuticals
VRTX
$123B
$1.66M 1%
13,423
-545
-4% -$68.7K
DATA
50
DELISTED
Tableau Software, Inc.
DATA
$1.63M 0.98%
14,115
-545
-4% -$58.9K
1
2
3 4

Similar funds

LOT
Lombard Odier Transatlantic Montreal, Quebec, Canada $105M AUM 13.73% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
PCM
Panning Capital Management New York $97.5M AUM 302.5% 1-Year Est. Return
EDRAML
Edmond de Rothschild Asset Management (Luxembourg) Luxembourg $95.2M AUM 19.45% 1-Year Est. Return
EC
Eachwin Capital New York $108M AUM 14.45% 1-Year Est. Return
SAMNY
Samsung Asset Management (New York) New York $109M AUM 14.33% 1-Year Est. Return
BCCM
Blue Clay Capital Management Minneapolis, Minnesota $88.7M AUM 6.88% 1-Year Est. Return
EIAM
Equinox Institutional Asset Management Princeton, New Jersey $87.9M AUM 1.01% 1-Year Est. Return

DG Capital Management (Massachusetts)'s Q2 2015 Portfolio in Review

As of Q2 2015, DG Capital Management (Massachusetts) held 76 positions worth $166M, down 0.07% from $166M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

DG Capital Management (Massachusetts) withdrew a net $7.01M in Q2 2015, closing 11 positions and reducing 29 holdings. Its most notable exit was Chubb, an estimated $2.79M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 37% a quarter earlier, followed by Financials and Technology.

Against the trend, DG Capital Management (Massachusetts) opened a new position in BioMarin Pharmaceuticals worth $3.33M.

  • DG Capital Management (Massachusetts)'s largest Q2 2015 buy was BioMarin Pharmaceuticals: 24,345 shares worth $3.33M.
  • DG Capital Management (Massachusetts) added most to Bristol-Myers Squibb in Q2 2015, an estimated $1.6M increase.
  • DG Capital Management (Massachusetts)'s biggest Q2 2015 reduction was Amgen, cutting an estimated $2.42M.
  • DG Capital Management (Massachusetts) fully exited Chubb in Q2 2015, selling an estimated $2.79M.
  • DG Capital Management (Massachusetts)'s ten largest holdings make up 30% of its $166M portfolio in Q2 2015.
  • DG Capital Management (Massachusetts) opened 12 new positions and closed 11 in Q2 2015.
  • DG Capital Management (Massachusetts)'s portfolio value fell 0.07% quarter-over-quarter to $166M.

Based on DG Capital Management (Massachusetts)'s 13F filing for Q2 2015, filed 11 Aug 2015.